CNS Drugs

期刊简介：CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes:- Overviews of contentious or emerging issues.- Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses.- Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.- Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry.- Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in CNS Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

【译文】CNS Drugs杂志促进临床精神病学和神经病学领域的合理药物治疗。该杂志包括：- 有争议或新兴问题的概述。- 提供关于神经和精神疾病药物治疗权威信息的全面叙述性评论。- 系统性评论，收集经验证据以回答特定研究问题，使用PRISMA声明中概述的明确、系统的方法。- Adis药物评论，包括神经病学和精神病学中较新和较老药物的特性和治疗位置。- 报告精心设计的研究结果，这些研究具有与临床实践强烈联系的原研文章，如临床药效学和药代动力学研究、临床试验、荟萃分析、结果研究和药物经济学和药物流行病学研究。- 文章可以附带额外的数字功能（包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画），旨在增加期刊内容的可见性、阅读量和教育价值。此外，CNS Drugs发表的文章可能还附有通俗易懂的摘要，以帮助那些对该领域有一定了解但不是深入了解的读者理解重要的医学进展。